|
1
|
Alzoubi KH, Gerges NZ, Aleisa AM and
Alkadhi KA: Levothyroxin restores hypothyroidism-induced impairment
of hippocampus-dependent learning and memory: Behavioral,
electrophysiological, and molecular studies. Hippocampus. 19:66–78.
2009. View Article : Google Scholar
|
|
2
|
Smith JW, Evans AT, Costall B and Smythe
JW: Thyroid hormones, brain function and cognition: a brief review.
Neurosci Biobehav Rev. 26:45–60. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu CL, Xu YX, Zhan Y, et al: Effect of
thyroxine on synaptotagmin 1 and SNAP-25 expression in dorsal
hippocampus of adult-onset hypothyroid rats. J Endocrinol Invest.
34:280–286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu DF, Wang ZX, Zhang DR, et al: fMRI
revealed neural substrate for reversible working memory dysfunction
in subclinical hypothyroidism. Brain. 129:2923–2930. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weimer RM, Richmond JE, Davis WS, Hadwiger
G, Nonet ML and Jorgensen EM: Defects in synaptic vesicle docking
in unc-18 mutants. Nat Neurosci. 6:1023–1030. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen J, Tareste DC, Paumet F, Rothman JE
and Melia TJ: Selective activation of cognate SNAREpins by
Sec1/Munc18 proteins. Cell. 128:183–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gengyo-Ando K, Kitayama H, Mukaida M and
Ikawa Y: A murine neural-specific homolog corrects cholinergic
defects in Caenorhabditis elegans unc-18 mutants. J
Neurosci. 16:6695–6702. 1996.PubMed/NCBI
|
|
8
|
Sakisaka T, Yamamoto Y, Mochida S, et al:
Dual inhibition of SNARE complex formation by tomosyn ensures
controlled neurotransmitter release. J Cell Biol. 183:323–337.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Wit H, Cornelisse LN, Toonen RF and
Verhage M: Docking of secretory vesicles is syntaxin dependent.
PLoS One. 1:e1262006.PubMed/NCBI
|
|
10
|
Han GA, Malintan NT, Collins BM, Meunier
FA and Sugita S: Munc18–1 as a key regulator of neurosecretion. J
Neurochem. 115:1–10. 2010.
|
|
11
|
Alzoubi KH, Gerges NZ and Alkadhi KA:
Levothyroxin restores hypothyroidism-induced impairment of LTP of
hippocampal CA1: electrophysiological and molecular studies. Exp
Neurol. 195:330–341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leentjens AF and Kappers EJ: Persistent
cognitive defects after corrected hypothyroidism. Psychopathology.
28:235–237. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu Y, Ning D, Wang F, Liu C, Xu Y, Jia X
and Zhu D: Effect of thyroxine on munc-18 and syntaxin-1 expression
in dorsal hippocampus of adult-onset hypothyroid rats. Eur J
Histochem. 56:e222012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vallortigara J, Alfos S, Micheau J,
Higueret P and Enderlin V: T3 administration in adult hypothyroid
mice modulates expression of proteins involved in striatal synaptic
plasticity and improves motor behavior. Neurobiol Dis. 31:378–385.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akasofu S, Kimura M, Kosasa T, Sawada K
and Ogura H: Study of neuroprotection of donepezil, a therapy for
Alzheimer’s disease. Chem Biol Interact. 175:222–226. 2008.
|
|
16
|
Giacobini E: Cholinesterase inhibitors
stabilize Alzheimer’s disease. Ann NY Acad Sci. 920:321–327.
2000.
|
|
17
|
Nordberg A and Svensson AL: Cholinesterase
inhibitors in the treatment of Alzheimer’s disease: a comparison of
tolerability and pharmacology. Drug Saf. 19:465–480. 1998.
|
|
18
|
Hestrin S: The reaction of acetylcholine
and other carboxylic acid derivatives with hydroxylamine, and its
analytical application. J Biol Chem. 180:249–261. 1949.PubMed/NCBI
|
|
19
|
Sokoloff L and Klee CB: The effect of
thyroid on protein synthesis in brain and other organs. Res Publ
Assoc Res Nerv Ment Dis. 43:371–386. 1966.PubMed/NCBI
|
|
20
|
Hepp R, Grant NJ, Chasserot-Golaz S, Aunis
D and Langley K: The hypophysis controls expression of SNAP-25 and
other SNAREs in the adrenal gland. J Neurocytol. 30:789–800. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Quintanar JL and Salinas E: Effect of
hypothyroidism on synaptosomal-associated protein of 25 kDa and
syntaxin-1 expression in adenohypophyses of rat. J Endocrinol
Invest. 25:754–758. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang HY, Sun CP, Jia XM, Gui L, Zhu DF and
Ma WQ: Effect of thyroxine on SNARE complex and synaptotagmin-1
expression in the prefrontal cortex of rats with adult-onset
hypothyroidism. J Endocrinol Invest. 35:312–316. 2012.PubMed/NCBI
|
|
23
|
Broedel O, Eravci M, Fuxius S, Smolarz T,
Jeitner A, Grau H, et al: Effects of hyper- and hypothyroidism on
thyroid hormone concentrations in regions of the rat brain. Am J
Physiol Endocrinol Metab. 285:E470–E480. 2003.PubMed/NCBI
|
|
24
|
Constantinou C, Margarity M and Valcana T:
Region-specific effects of hypothyroidism on the relative
expression of thyroid hormone receptors in adult rat brain. Mol
Cell Biochem. 278:93–100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Molinengo L, Cassone MC and Oggero L:
Action of hypo- and hyperthyroidism on the postmortal decay of
acetylcholine in the rat spinal cord. Neuroendocrinology. 42:28–31.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gould E and Butcher LL: Developing
cholinergic basal forebrain neurons are sensitive to thyroid
hormone. J Neurosci. 9:3347–3358. 1989.PubMed/NCBI
|
|
27
|
Ahmed MT, Sinha AK, Pickard MR, Kim KD and
Ekins RP: Hypothyroidism in the adult rat causes brain
region-specific biochemical dysfunction. J Endocrinol. 138:299–305.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mehndiratta MM, Pandey S and Kuntzer T:
Acetylcholinesterase inhibitor treatment for myasthenia gravis.
Cochrane Database Syst Rev. 2:CD0069862011.
|
|
29
|
Kroker KS, Rast G, Giovannini R, Marti A,
Dorner-Ciossek C and Rosenbrock H: Inhibition of
acetylcholinesterase and phosphodiesterase-9A has differential
effects on hippocampal early and late LTP. Neuropharmacology.
62:1964–1974. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barnes CA, Meltzer J, Houston F, Orr G,
McGann K and Wenk GL: Chronic treatment of old rats with donepezil
or galantamine: effects on memory, hippocampal plasticity and
nicotinic receptors. Neuroscience. 99:17–23. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shahrara S, Drvota V and Sylvén C: Organ
specific expression of thyroid hormone receptor mRNA and protein in
different human tissues. Biol Pharm Bull. 22:1027–1033. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ladinsky H, Consolo S, Peri G and
Garattini S: Acetylcholine, choline and choline acetyltransferase
activity in the developing brain of normal and hypothyroid rats. J
Neurochem. 19:1947–1952. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wekking EM, Appelhof BC, Fliers E, et al:
Cognitive functioning and well-being in euthyroid patients on
thyroxine replacement therapy for primary hypothyroidism. Eur J
Endocrinol. 153:747–753. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Wit H, Walter AM, Milosevic I,
Gulyás-Kovács A, Riedel D, Sørensen JB and Verhage M:
Synaptotagmin-1 docks secretory vesicles to syntaxin-1/SNAP-25
acceptor complexes. Cell. 138:935–946. 2009.PubMed/NCBI
|
|
35
|
van Doorn J, Roelfsema F and van der Heide
D: Concentrations of thyroxine and 3,5,3′-triiodothyronine at 34
different sites in euthyroid rats as determined by an isotopic
equilibrium technique. Endocrinology. 117:1201–1208. 1985.
|
|
36
|
Dong H, Yuede CM, Coughlan CA, Murphy KM
and Csernansky JG: Effects of donepezil on amyloid-beta and synapse
density in the Tg2576 mouse model of Alzheimer’s disease. Brain
Res. 1303:169–178. 2009.PubMed/NCBI
|
|
37
|
Mori E, Hashimoto M, Krishnan KR and
Doraiswamy PM: What constitutes clinical evidence for
neuroprotection in Alzheimer disease: support for the
cholinesterase inhibitors. Alzheimer Dis Assoc Disord. 20(2 Suppl
1): S19–S26. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Riepe MW: Cholinergic treatment: what are
the early neuropathological targets. Eur J Neurol. 12:3–9. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Alcántara-González F, Mendoza-Perez CR,
Zaragoza N, et al: Combined administration of cerebrolysin and
donepezil induces plastic changes in prefrontal cortex in aged
mice. Synapse. 66:938–949. 2012.PubMed/NCBI
|
|
40
|
Yoshiyama Y, Kojima A, Ishikawa C and Arai
K: Anti-inflammatory action of donepezil ameliorates tau pathology,
synaptic loss, and neurodegeneration in a tauopathy mouse model. J
Alzheimers Dis. 22:295–306. 2010.PubMed/NCBI
|
|
41
|
Autio H, Mätlik K, Rantamäki T, et al:
Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin
receptors in the mouse hippocampus. Neuropharmacology.
61:1291–1296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shen H, Kihara T, Hongo H, et al:
Neuroprotection by donepezil against glutamate excitotoxicity
involves stimulation of alpha7 nicotinic receptors and
internalization of NMDA receptors. Br J Pharmacol. 161:127–139.
2010. View Article : Google Scholar
|
